scispace - formally typeset
Open AccessBookDOI

Green and sustainable pharmacy

Klaus Kümmerer, +1 more
- Iss: 1
Reads0
Chats0
TLDR
This book focuses on the use and disposal of pharmaceuticals in the Netherlands, and the role of patients and the environment in the development and use of these products and services.
Abstract: 
General Aspects.- Why Green and Sustainable Pharmacy?.- Pharmaceuticals in the Environment: Moving from a Problem to a Solution.- Pharmaceuticals in Society.- Green(er) Pharmacy.- Creating a Sustainability Culture - A (Human Resources) Management Perspective for Sustainable Pharmacy.- Reducing the Ecological Footprint of Pharmaceutical Usage: Linkages Between Healthcare Practices and the Environment.- Development, Synthesis and Production and Distribution of Pharmaceuticals.- Ecopharmacostewardship - A Pharmaceutical Industry Perspective.- Protein and Peptide Therapeuticals: An Example of "Benign by Nature" Active Pharmaceutical Ingredients.- Rational Design of Molecules by Life Cycle Engineering.- Use and Disposal of Pharmaceuticals.- Options for a More Environmentally Friendly Handling of Pharmaceuticals.- Disposal of Pharmaceutical Waste in Households - A European Survey.- Pharmaceutical Waste: The Patient Role.- Forecast of Pharmaceutical Consumption in the Netherlands Using Demographic Projections.- Emission Management.- Point Sources of Human Pharmaceuticals into the Aquatic Environment.- Pharmaceuticals for Human Use: An Integrated Strategy for Reducing the Contamination of Water Bodies.- Experiences with the Swedish Environmental Classification Scheme.- Incentives, Regulation and the Market.- European Regulations.- Regulation and the Market-Incentives.- Do Pharmaceuticals in the Environment Present an Investment Risk?.- Outlook.- Sustainable Health Products and Service Solutions in the Year 2050.- Summary and Outlook.

read more

Content maybe subject to copyright    Report

Klaus Kiimmerer
•
Maximilian Hempel
Editors
Green and Sustainable
Pharmacy
4y Springer
Contents
Part I General Aspects
1 Why Green and Sustainable Pharmacy? 3
Klaus Kummerer
2 Pharmaceuticals in the Environment: Moving from a
Problem to a Solution 11
John
P.
Sumpter
3 Pharmaceuticals in Society 23
David J. Triggle
4 Green(er) Pharmacy 37
James H. Clark, Simon
W.
Breeden, and Louise Summerton
5 Creating a Sustainability Culture - A (Human Resources)
Management Perspective for Sustainable Pharmacy 61
Michael Laufer
6 Reducing the Ecological Footprint of Pharmaceutical
Usage: Linkages Between Healthcare Practices and the Environment 77
Christian G. Daughton and Ilene S. Ruhoy
Part II Development, Synthesis and Production and
Distribution of Pharmaceuticals
7 Ecopharmacostewardship - A Pharmaceutical Industry Perspective 105
David Taylor
8 Protein and Peptide Therapeuticals: An Example of
"Benign by Nature" Active Pharmaceutical Ingredients 127
Jiirg Oliver Straub
9 Rational Design of Molecules by Life Cycle Engineering 135
Klaus Kiimmerer
xii Contents
Part III Use and Disposal of Pharmaceuticals
10 Options for a More Environmentally Friendly Handling
of Pharmaceuticals 149
Konrad Gotz and Jutta Deffner
11 Disposal of Pharmaceutical Waste in Households -
A European Survey 165
Gerald Vollmer
12 Pharmaceutical Waste: The Patient Role 179
Staffan Castensson and Anders Ekedahl
13 Forecast of Pharmaceutical Consumption in the
Netherlands Using Demographic Projections 201
Monique van der Aa and Geertjan Kommer
Part IV Emission Management
14 Point Sources of Human Pharmaceuticals into the Aquatic
Environment 211
Kevin
V.
Thomas and Katherine H. Langford
15 Pharmaceuticals for Human Use: An Integrated Strategy
for Reducing the Contamination of Water Bodies 225
Florian Keil
16 Experiences with the Swedish Environmental Classification Scheme 243
Ake Wennmalm and Bo Gunnarsson
Part V Incentives, Regulation and the Market
17 European Regulations 253
Eleftheria Kampa, Thomas Dworak, Cornelius Laaser, and
Rodrigo Vidaurre
18 Regulation and the Market-Incentives 279
Benoit Roig and Evelyne Touraud
19 Do Pharmaceuticals in the Environment Present an
Investment Risk? 287
Andreas Holzer
Part VI Outlook
20 Sustainable Health Products and Service Solutions in the
Year 2050 . 295
Ludwig Metz and Klaus Kummerer
Contents xiii
21 Summary and Outlook 299
Klaus Kummerer Maximilian Hempel,
Hans-Christian Schaefer, and Florian Keil
Index 305
Citations
More filters
Journal ArticleDOI

Transdisciplinarity: Between mainstreaming and marginalization

Thomas Jahn, +2 more
- 01 Jul 2012 - 
TL;DR: In this paper, the authors identify main features of an emerging shared framework of transdisciplinarity and propose a conceptual model of trans-discipline that can be used by science and science policy to characterize different types of trans discipline and their corresponding demands on integration.
Journal ArticleDOI

Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery

Poovi Ganesan, +1 more
- 01 Dec 2017 - 
TL;DR: This review highlights the simple and easily scaled-up novel SLN and NLC along with their different production techniques, hurdles, and strategies for the production of LNs, characterization, lyophilization and drug release and summarizes the research findings reported by the different researchers regarding the different method of preparation, excipients and their significant findings.
Journal ArticleDOI

Biodegradability of organic nanoparticles in the aqueous environment.

Klaus Kümmerer, +3 more
- 01 Mar 2011 - 
TL;DR: Fullerenes and all carbon nanotubes did not biodegrade at all, while starch and cellulose nanoparticles biodegrades to similar levels as their macroscopic counterparts, however, neither comfortably met the criterion for ready biodegradability.
Journal ArticleDOI

Ethinyl Estradiol and Other Human Pharmaceutical Estrogens in the Aquatic Environment: A Review of Recent Risk Assessment Data

James P. Laurenson, +3 more
- 28 Jan 2014 - 
TL;DR: The results indicate that mean-flow long-term predicted environmental concentrations of EE2 in approximately 99% or more of US surface water segments downstream of wastewater treatment plants are lower than a predicted no-effect concentration (PNEC) for aquatic chronic toxicity of 0.1 ng/L.
Book ChapterDOI

Illicit drugs: contaminants in the environment and utility in forensic epidemiology.

Christian G. Daughton
- 01 Jan 2011 - 
TL;DR: The state of knowledge up until mid-2010 regarding the origin, occurrence, fate, and potential for biological effects of IDIs in the environment is covered, and the growing interest in FEUDS as a methodological approach for estimating collective public usage of illicit drugs points to the feasibility of mining other types of chemical information from sewage.
References
More filters
Book ChapterDOI

Strategic Management: THE STAKEHOLDER APPROACH

R. Edward Freeman
Book

Strategic Management: A Stakeholder Approach

R. Edward Freeman, +1 more
TL;DR: The Stakeholder Approach: 1. Managing in turbulent times 2. The stakeholder concept and strategic management 3. Strategic Management Processes: 4. Setting strategic direction 5. Formulating strategies for stakeholders 6. Implementing and monitoring stakeholder strategies 7. Conflict at the board level 8. The functional disciplines of management 9. The role of the executive as mentioned in this paper.
Journal ArticleDOI

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, +3 more
- 15 Jan 1997 - 
TL;DR: Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described in this article, where the rule of 5 is used to predict poor absorption or permeability when there are more than 5 H-bond donors, 10 Hbond acceptors, and the calculated Log P (CLogP) is greater than 5 (or MlogP > 415).
Journal ArticleDOI

The International HapMap Project

John W. Belmont, +145 more
- 18 Dec 2003 - 
TL;DR: The HapMap will allow the discovery of sequence variants that affect common disease, will facilitate development of diagnostic tools, and will enhance the ability to choose targets for therapeutic intervention.
Book

Green Chemistry: Theory and Practice

Paul T. Anastas, +1 more
TL;DR: Green Chemistry: What is green chemistry? as discussed by the authors presents the principles of green chemistry and evaluates the impact of chemistry on the environment. But, it is not a complete overview of all of the issues involved in green chemistry.
Related Papers (5)

The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges.

Klaus Kümmerer
- 01 Jun 2009 - 

Pharmaceuticals in the environment : sources, fate, effects and risks

Klaus Kümmerer

Pharmaceuticals and personal care products in the environment: agents of subtle change?

Christian G. Daughton, +1 more
- 01 Dec 1999 - 

Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data

Thomas Heberer
- 10 May 2002 - 

Ecotoxicology of human pharmaceuticals.

Karl Fent, +2 more
- 10 Feb 2006 -